Healthpeak Properties, Inc. (NYSE:DOC) Stock Position Reduced by Schroder Investment Management Group

Schroder Investment Management Group trimmed its holdings in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 22.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,636,630 shares of the real estate investment trust's stock after selling 747,015 shares during the quarter. Schroder Investment Management Group owned about 0.38% of Healthpeak Properties worth $52,680,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company bought a new position in shares of Healthpeak Properties in the third quarter worth $13,062,000. FMR LLC acquired a new stake in Healthpeak Properties in the third quarter worth about $67,058,000. Townsquare Capital LLC bought a new position in Healthpeak Properties in the 3rd quarter valued at about $226,000. Glenmede Trust Co. NA acquired a new position in Healthpeak Properties during the 3rd quarter valued at about $359,000. Finally, CreativeOne Wealth LLC bought a new stake in shares of Healthpeak Properties during the 3rd quarter worth about $210,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Scotiabank decreased their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a report on Friday, February 28th. Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target on the stock in a research report on Wednesday, January 15th. Wedbush cut their price objective on Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating for the company in a report on Friday, February 14th. Wells Fargo & Company lowered their target price on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating on the stock in a report on Tuesday, December 10th. Finally, Robert W. Baird cut their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a report on Tuesday, February 11th. Four investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $23.83.

Remove Ads

Healthpeak Properties Trading Down 5.3 %

Shares of Healthpeak Properties stock traded down $1.04 during trading on Friday, hitting $18.42. The stock had a trading volume of 6,634,080 shares, compared to its average volume of 4,833,224. Healthpeak Properties, Inc. has a 1 year low of $17.80 and a 1 year high of $23.26. The stock has a 50 day simple moving average of $20.11 and a 200 day simple moving average of $21.01. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $12.89 billion, a PE ratio of 52.63, a P/E/G ratio of 2.17 and a beta of 1.14.

Healthpeak Properties Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were issued a dividend of $0.305 per share. This is an increase from Healthpeak Properties's previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.62%. Healthpeak Properties's payout ratio is currently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.